Literature DB >> 27247994

Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University.

Takashi Hashimoto1, Zhexiong Jin1, Norito Ishii1.   

Abstract

OBJECTIVES: Using our serological diagnostic criteria, we selected 105 Japanese patients with epidermolysis bullosa acquisita (EBA), an autoimmune bullous disease (AIBD) reacting with type VII collagen, from our cohort of 5063 AIBD patients.
METHODS: We examined the patients clinically and immunologically.
RESULTS: We found diversity of clinical manifestations in both cutaneous and oral mucosal lesions and a high rate of inflammatory-type EBA patients in Japan. Common treatments were systemic steroids, followed by immunosuppressives, DDS, tetracycline/minocycline and colchicine. Immunological studies revealed that indirect immunofluorescence of 1M-NaCl-split skin, immunoblotting of dermal extract, and type VII collagen ELISA were sensitive methods, with possible multiplicity of circulating autoantibodies against other basement membrane autoantigens.
CONCLUSION: The present study analyzed the largest cohort of EBA patients, confirming the scarcity of EBA (only 105 of the 5063 AIBD patients), and showed that the three serological tests are useful for the diagnosis of EBA.

Entities:  

Keywords:  Autoantigens; ELISA; autoimmune bullous diseases; basement membrane zone; diagnosis; epidermolysis bullosa acquisita; immunoblotting; immunofluorescence; treatment; type VII collagen

Mesh:

Substances:

Year:  2016        PMID: 27247994     DOI: 10.1080/1744666X.2016.1196136

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  4 in total

1.  Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity.

Authors:  Maike M Holtsche; Nina van Beek; Takashi Hashimoto; Giovanni Di Zenzo; Detlef Zillikens; Catherine Prost-Squarcioni; Matthias Titeux; Alain Hovnanian; Enno Schmidt; Stephanie Goletz
Journal:  Acta Derm Venereol       Date:  2021-03-23       Impact factor: 3.875

2.  The development of mucous membrane epidermolysis bullosa acquisita in a pediatric patient.

Authors:  Kathryn Rentfro; Megan Arthur
Journal:  JAAD Case Rep       Date:  2021-03-10

3.  Case Report: Variety of Target Antigens During 1 Year Follow-Up of a Patient Initially Diagnosed With Bullous Pemphigoid.

Authors:  Hua Qian; Zhijun Zhou; Luhuai Shi; Huicheng Li; Weijun Liu; Yong Ai; Yangmin Gao; Suying Feng; Takashi Hashimoto; Xiaoguang Li
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

4.  Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients.

Authors:  Hiroaki Iwata; Artem Vorobyev; Hiroshi Koga; Andreas Recke; Detlef Zillikens; Catherine Prost-Squarcioni; Norito Ishii; Takashi Hashimoto; Ralf J Ludwig
Journal:  Orphanet J Rare Dis       Date:  2018-09-04       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.